by John A. Jenkins | Feb 11, 2026 | FOIA, News Media
FOIAengine: Hundreds of Requests Probing How FDA Weighs Risk and Responds to Warnings A new tranche of just-released Freedom of Information Act requests from news organizations shows how reporters are using the act as an investigative tool to reconstruct internal...
by John A. Jenkins | Feb 4, 2026 | FDA, FOIA, Litigation, Pharmaceuticals, Stock Market
FOIAengine: Media Requests Were Warnings, Months Before Bad News Hit In the early days of the Covid pandemic, there was big money on the line as pharmaceutical companies scrambled to produce vaccines. The world needed a miracle. The companies that could deliver it...
by Randy E. Miller | Jan 22, 2026 | FDA, FOIA, Law Firms
FOIAengine: A Tale of Two Law Firms When most people think about the Freedom of Information Act, they imagine journalists prying loose hidden facts or activists holding officials accountable. But FOIA is also a workhorse tool for lawyers. As two law firms’ 2025 FOIA...
by John A. Jenkins | Jan 14, 2026 | FDA, FOIA, News Media, Pharmaceuticals
FOIAengine: Warning Letters and Inspection Reports in the Spotlight Freedom of Information Act requests filed with the Food and Drug Administration by hedge funds last month revealed big financial players closely eyeing warning letters, enforcement documents, and...
by John A. Jenkins | Jan 8, 2026 | FDA, FOIA, News Media, Pharmaceuticals
FOIAengine: Growing Scrutiny of Drug Safety and Enforcement As GLP-1 weight-loss drugs surge in popularity, major news organizations are pressing the Food and Drug Administration for internal records that reveal what regulators knew about reports of dangers...
by Randy E. Miller | Dec 18, 2025 | FOIA, FTC, Politics
FOIAengine: Was the FTC Involved in Operation “Arctic Frost”? The conservative Heritage Foundation continues to flood federal agencies with Freedom of Information Act requests seeking detailed records about the machinations of the departed Biden administration. ...
